Abstract
Combined ligand-based and target-based drug design approaches provide a synergistic advantage over either method individually. Therefore, we set out to develop a powerful virtual screening model to identify novel molecular scaffolds as potential leads for the human KOP (hKOP) receptor employing a combined approach. Utilizing a set of recently reported derivatives of salvinorin A, a structurally unique KOP receptor agonist, a pharmacophore model was developed that consisted of two hydrogen bond acceptor and three hydrophobic features. The model was cross-validated by randomizing the data using the CatScramble technique. Further validation was carried out using a test set that performed well in classifying active and inactive molecules correctly. Simultaneously, a bovine rhodopsin based “agonist-bound” hKOP receptor model was also generated. The model provided more accurate information about the putative binding site of salvinorin A based ligands. Several protein structure-checking programs were used to validate the model. In addition, this model was in agreement with the mutation experiments carried out on KOP receptor. The predictive ability of the model was evaluated by docking a set of known KOP receptor agonists into the active site of this model. The docked scores correlated reasonably well with experimental pK i values. It is hypothesized that the integration of these two independently generated models would enable a swift and reliable identification of new lead compounds that could reduce time and cost of hit finding within the drug discovery and development process, particularly in the case of GPCRs.













Similar content being viewed by others
References
Bleicher KH, Bohm HJ, Muller K, Alanine AI (2004) Curr Opin Chem Biol 8:287
Oprea TI, Matter H (2004) Curr Opin Chem Biol 8:349
Bajorath J (2001) J Chem Inf Comput Sci 41:233
Good AC, Krystek SR, Mason JS (2000) Drug Discov Today 5:61
Patel Y, Gillet VJ, Bravi G, Leach AR (2002) J Comput Aided Mol Des 16:653
Schneider G, Böhm HJ (2002) Drug Discov Today 7:64
Abagyan R, Totrov M (2001) Curr Opin Chem Biol 5:375
Bissantz C, Folkers G, Rognan D (2000) J Med Chem 43:4759
Taylor RD, Jewsbury PJ, Essex JW (2002) J Comput Aided Mol Des 16:151
Brooijmans N, Kuntz ID (2003) Annu Rev Biophys Biomol Struct 32:335
Lyne PD (2002) Drug Discov Today 7:047
Halperin I, Ma B, Wolfson H, Nussinov R (2002) Proteins 47:409
Guner O (ed) (2000) Pharmacophore perception, development and use in drug design. International University Line, La Jolla, CA
Marrone TJ, Briggs JM, McCammon JA (1997) Ann Rev Pharmacol Toxicol 37:71
Dixon JS (1997) Proteins Suppl 1:198
Tame JRH (1999) J Comput Aided Mol Des 13:99
Gohlke H, Klebe G (2001) Curr Opin Struct Biol 11:231
Schwalbe H, Wess G (2002) Chembiochem 3:915
Flower DR (1999) Biochim Biophys Acta 1422:207
Wise A, Gearing K, Rees S (2002) Drug Discov Today 7:235
Drews J (2000) Science 287:1960
Takeda S, Kadowaki S, Haga T, Takaesu H, Mitaku S (2002) FEBS Lett 520:97
Collins FS (2004) Nature 431:931
Marriott DP, Dougall IG, Meghani P, Liu YJ, Flower DR (1999) J Med Chem 42:3210
Flohr S, Kurz M, Kostenis E, Brokovich A, Fournier A, Klabunde T (2002) J Med Chem 45:799
Pebay-Peyroula E, Rummel G, Rosenbusch JP, Landau EM (1997) Science 277:1676
Belrhali H, Nollert P, Royant A, Menzel C, Rosenbusch JP, Landau EM, Pebay-Peyroula E (1999) Struct Fold Des 7:909
Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M (2000) Science 289:739
Teller DC, Okada T, Behnke CA, Palczewski K, Stenkamp RE (2001) Biochemistry 40:7761
Ballesteros J, Palczewski K (2001) Curr Opin Drug Discov Dev 4:561
Okada T, Sugihara M, Bondar AN, Elstner M, Entel P, Buss V (2004) J Mol Biol 342:571
Beeley NRA, Sage C (2003) Targets 2:19
Evers A, Klabunde T (2005) J Med Chem 48:1088
Varady J, Wu X, Fang X, Min J, Hu Z, Levant B, Wang S (2003) J Med Chem 46:4377
Bissantz C, Bernard P, Hibert M, Rognan D (2003) Proteins 50:5
Evers A, Hessler G, Matter H, Klabunde T (2005) J Med Chem 48:5448
Evers A, Klebe G (2004) J Med Chem 47:5381
Kieffer BL (1995) Cell Mol Neurobiol 15:615
Ulloa-Aguirre A, Stanislaus D, Janovick JA, Conn PM (1999) Arch Med Res 30:420
Gether U (2000) Endocr Rev 21:90
Chen Y, Mestek A, Liu J, Yu L (1993) Biochem J 295:625
Evans CJ, Keith DE Jr, Morrison H, Magendzo K, Edwards RH (1992) Science 258:1952
Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG (1992) Proc Natl Acad Sci USA 89:12048
Yasuda K, Raynor K, Kong H, Breder CD, Takeda J, Reisine T, Bell GI (1993) Proc Natl Acad Sci USA 90:6736
Meng F, Xie GX, Thompson RC, Mansour A, Goldstein A, Watson SJ, Akil H (1993) Proc Natl Acad Sci USA 90:9954
Chen Y, Mestek A, Liu J, Hurley JA, Yu L (1993) Mol Pharmacol 44:8
Fukuda K, Kato S, Mori K, Nishi M, Takeshima H (1993) FEBS Lett 327:311
Knapp RJ, Malatynska E, Fang L, Li X, Babin E, Nguyen M, Santoro G, Varga EV, Hruby VJ, Roeske WR et al (1994) Life Sci 54:PL463
Wang JB, Johnson PS, Persico AM, Hawkins AL, Griffin CA, Uhl GR (1994) FEBS Lett 338:17
Mansson E, Bare L, Yang D (1994) Biochem Biophys Res Commun 202:1431
Mollereau C, Parmentier M, Mailleux P, Butour JL Moisand C, Chalon P, Caput D, Vassart G, Meunier JC (1994) FEBS Lett 341:33
Meunier JC (1997) Eur J Pharmacol 340:1
Pogozheva ID, Przydzial MJ, Mosberg HI (2005) AAPS J 7:E434
Metcalf MD, Coop A (2005) AAPS J 7:E704
Rees DC (1992) Prog Med Chem 29:109
Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB (2002) Proc Natl Acad Sci USA 99:11934
Chavkin C, Sud S, Jin W, Stewart J, Zjawiony JK, Siebert DJ, Toth BA, Hufeisen SJ, Roth BL (2004) J Pharmacol Exp Ther 308:1197
Siebert DJ (1994) J Ethnopharmacol 43:53
Wang Y,Tang K, Inan S, Siebert D, Holzgrabe U, Lee DY, Huang P, Li JG, Cowan A, Liu-Chen LY (2005) J Pharmacol Exp Ther 312:220
Yan F, Roth BL (2004) Life Sci 75:2615
Ortega A, Blount JF, Manchand PS (1982) J Chem Soc Perkins Trans 1:505
Wasson RG (1962) Bot Mus Leafl Harv Univ 20:77
Valdes LJ, Butler WM, Hatfield GM, Paul AG, Koreeda M (1984) J Org Chem 49:4716
Valdes LJ III, Diaz JL, Paul AG (1983) J Ethnopharmacol 7:287
Rees DC, Hunter JC (1990) Comprehensive medicinal chemistry. Pergammon, New York, p 805
Beguin C, Richards MR, Wang Y, Chen Y, Liu-Chen LY, Ma Z, Lee DY, Carlezon WA Jr, Cohen BM (2005) Bioorg Med Chem Lett 15:2761
Mowry M, Mosher M, Briner W (2003) J Psychoactive Drugs 35:379
Valdes LJ III (1994) J Psychoactive Drugs 26:277
McCurdy CR, Sufka KJ, Smith GH, Warnick JE, Nieto MJ (2006) Pharmacol Biochem Behav 83:109
Evers A, Gohlke H, Klebe GJ (2003) Mol Biol 334:327
Catalyst, version 48, Accelrys: Burlington, MA
Thompson JD, Higgins DG, Gibson TJ (1994) Nucleic Acid Res 22:4673
InsightII, Molecular Modeling Program Package, Accelrys: 9685 Sranton Road, San Diego, CA 92121–3752, USA
Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) J Appl Cryst 26:283
GOLDversion 21, Cambridge Crystallographic Data Centre: Cambridge, UK
Sybyl version 72, Tripos Inc, St Louis, MO, USA
Munro TA, Rizzacasa MA, Roth BL, Toth BA, Yan F (2005) J Med Chem 48:345
Harding WW, Tidgewell K, Byrd N, Cobb H, Dersch CM, Butelman ER, Rothman RB, Prisinzano TE (2005) J Med Chem 48:4765
Lee DY, He M, Kondaveti L, Liu-Chen LY, Ma Z, Wang Y, Chen Y, Li JG, Beguin C, Carlezon WA Jr, Cohen B (2005) Bioorg Med Chem Lett 15:4169
Lee DY, Karnati VV, He M, Liu-Chen LY, Kondaveti L, Ma Z, Wang Y, Chen Y, Beguin C, Carlezon WA Jr, Cohen B (2005) Bioorg Med Chem Lett 15:3744
Li H, Sutter J, Hoffman R (1999) In: Guner OF (ed) Pharmacophore: perception, development and use in drug design. International University Line, La Jolla CA, p 173
Gund P (1977) In: Hahn FE (ed) Progress in molecular and subcellular biology, vol 5. Springer-Verlag, New York, p 117
Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M (1983) J Comp Chem 4:187
Smellie A, Teig SL, Towbin P (1999) J Comput Chem 16:171
English philosopher and Franciscan Monk, William of Ockham, 1285
Sutter J, Guner OF, Hoffman R, Li H, Waldman M (1999) In: Guner OF (ed) Pharmacophore: perception, development and use in drug design. International University Line, La Jolla CA, p 501
Fischer R (1966) The design of experiments, 8th edn, Chapter II. Hafner Publishing Co, New York
Boeckmann B, Bairoch A, Apweiler R, Blatter MC, Estreicher A, Gasteiger E, Martin MJ, Michoud K, O’Donovan C, Phan I, Pilbout S, Schneide M (2003) Nucleic Acids Res 31:365
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) Nucleic Acids Res 28:235
Henikoff S, Henikoff JG (1992) Proc Natl Acad Sci USA 89:10915
Sali A, Blundell TL (1993) J Mol Biol 234:779
Marti-Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F et al (2000) Annu Rev Biophys Biomol Struct 29:291
Yan F, Mosier PD, Westkaemper RB, Stewart J, Zjawiony JK, Vortherms TA, Sheffler DJ, Roth BL (2005) Biochemistry 44:8643
Andersen HC (1980) J Chem Phys 72:2384
Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) J Mol Biol 267:727
Ballesteros JA, Weinstein H (1995) Methods Neurosci 25:366
Costanzi S, Lambertucci C, Vittori S, Volpini R, Cristalli G (2003) J Mol Graph Model 21:253
Hulme EC, Lu ZL, Ward SDC, Allman K, Curtis CA (1999) Eur J Pharmacol 375:247
Ghanouni P, Steenhuis JJ, Farrens DL, Kobilka BK (2001) Proc Natl Acad Sci USA 98:5997
Farrens DL, Altenbach C, Yang K, Hubbell WL, Khorana HG (1996) Science 274:768
Kim JM, Altenbach C, Kono M, Oprian DD, Hubbell WL, Khorana HG (2004) Proc Natl Acad Sci USA 101:12508
Hubbell WL, Altenbach C, Hubbell CM, Khorana HG (2003) Adv Protein Chem 63:243
Hanson SM, Francis DJ, Vishnivetskiy SA, Kolobova EA, Hubbell WL, Klug CS, Gurevich VV (2006) Proc Natl Acad Sci USA 103:4900
Patel AB, Crocker E, Reeves PJ, Getmanova EV, Eilers M, Khorana HG, Smith SO (2005) J Mol Biol 347:803
Han SJ, Hamdan FF, Kim SK, Jacobson KA, Bloodworth LM, Li B, Wess J (2005) J Biol Chem 280:34849
Becker OM, Marantz Y, Shacham S, Inbal B, Heifetz A, Kalid O, Bar-Haim S, Warshaviak D, Fichman M, Noiman S (2004) Proc Natl Acad Sci USA 101:11304
Hiramoto T, Nonaka Y, Inoue K, Yamamoto T, Omatsu-Kanbe M, Matsuura H, Gohda K, Fujita N (2004) J Pharmacol Sci 95:81
(a) Subramanian G, Paterlini MG, Larson D, Portoghese PS, Ferguson DM (1998) J Med Chem 41:4777; (b) Pogozheva ID, Lomize AL, Mosberg HI (1998) Biophys J 75:612; (c) Cappelli A, Anzini M, Vomero S, Menziani MC, De Benedetti PG, Sbacchi M, Clarke GD, Mennuni L (1996) J Med Chem 39:860; (d) Metzger TG, Paterlini MG, Portoghese PS, Ferguson DM (1996) Neurochem Res 21:1287; (e) Strahs D, Weinstein H (1997) Protein Eng 10:1019
Lee KW, Briggs JM (2004) Proteins 54:693
Archer E, Maigret B, Escrieut C, Pradayrol L, Fourmy D (2003) Trends Pharmacol Sci 24:36
Oliveira L, Hulsen T, Lutje Hulsik D, Paiva AC, Vriend G (2004) FEBS Lett 564:269
Waldhoer M, Bartlett SE, Whistler JL (2004) Annu Rev Biochem 73:953
(a) Karnik SS, Khorana HG (1990) J Biol Chem 265:17520; (b) Kurtenbach E, Curtis CA, Pedder EK, Aitken A, Harris AC, Hulme EC (1990) J Biol Chem 265:13702; (c) Dohlman HG, Caron MG, DeBlasi A, Frielle T, Lefkowitz RJ (1990) Biochemistry 29:2335
Kane BE, Nieto MJ, McCurdy CR, Ferguson DM (2006) FEBS J 273:1966
(a) Thirstrup K, Elling CE, Hjorth SA, Schwartz TW (1996) J Biol Chem 271:7875; (b) Hjorth SA, Thirstrup K, Schwartz TW (1996) Mol Pharmacol 50:977 (c) Xue JC, Chen C, Zhu J, Kunapuli S, DeRiel JK, Yu L, Liu-Chen LY (1994) J Biol Chem, 269:30195
Ballesteros J, Kitanovic S, Guarnieri F, Davies P, Fromme BJ, Konvicka K, Chi L, Millar RP, Davidson JS, Weinstein H, Sealfon SC (1998) J Biol Chem 273:10445
Scheer A, Fanelli F, Costa T, De Benedetti PG, Cotecchia S (1996) EMBO J 15:3566
Fritze O, Filipek S, Kuksa V, Palczewski K, Hofmann KP, Ernst OP (2003) Proc Natl Acad Sci USA 100:290
Zhou W, Flanagan C, Ballesteros JA, Konvicka K, Davidson JS, Weinstein H, Millar RP, Sealfon SC (1994) Mol Pharmacol 45:165
Sealfon SC, Chi L, Ebersole BJ, Rodic V, Zhang D, Ballesteros JA, Weinstein H (1995) J Biol Chem 270:16683
Folkers G (1998) In: Codding PW (ed) Structure-based drug design experimental and computational approaches. Kluwer Academic Publishers, Norwell, MA USA, p 271
Acknowledgements
Support for this work was provided by NIDA grant DA017360.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Singh, N., Chevé, G., Ferguson, D.M. et al. A combined ligand-based and target-based drug design approach for G-protein coupled receptors: application to salvinorin A, a selective kappa opioid receptor agonist. J Comput Aided Mol Des 20, 471–493 (2006). https://doi.org/10.1007/s10822-006-9067-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-006-9067-x